Apolipoprotein E isoform-dependent microglia migration

FASEB Journal

Volumn 25, Issue 6, 2011, Pages 2082-2091

  Cudaback, Eiron ^a   Li, Xianwu ^a   Montine, Kathleen S ^a   Montine, Thomas J ^a   Keene, C Dirk ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ATP; C5a; ERK; Receptor associated protein; Targeted replacement

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; COMPLEMENT COMPONENT C5A; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME PHOSPHORYLATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOLIPOPROTEINS E; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; PROTEIN ISOFORMS;

MUS;

EID: 79957894209     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-176891     Document Type: Article

References (67)

1. Amor, S., Puentes, F., Baker, D., and van der Valk, P. Inflammation in neurodegenerative diseases. Immunology 129, 154-169
2. Festoff, B. W., Ameenuddin, S., Arnold, P. M., Wong, A., Santacruz, K. S., and Citron, B. A. (2006) Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury. J. Neurochem. 97, 1314-1326
3. Howell, O. W., Rundle, J. L., Garg, A., Komada, M., Brophy, P. J., and Reynolds, R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J. Neuropathol. Exp. Neurol. 69, 1017-1033
4. Malm, T. M., Magga, J., Kuh, G. F., Vatanen, T., Koistinaho, M., and Koistinaho, J. (2008) Minocycline reduces engraftment and activation of bone marrow-derived cells but sustains their phagocytic activity in a mouse model of Alzheimer's disease. Glia 56, 1767-1779
5. Neumann, J., Gunzer, M., Gutzeit, H. O., Ullrich, O., Reymann, K. G., and Dinkel, K. (2006) Microglia provide neuroprotection after ischemia. FASEB J. 20, 714-716 (Pubitemid 46671191)
6. Seabrook, T. J., Jiang, L., Maier, M., and Lemere, C. A. (2006) Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice. Glia 53, 776-782
7. Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D. K., Ischiropoulos, H., and Przedborski, S. (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771 (Pubitemid 35386294)
8. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., and Koistinaho, J. (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95, 15769-15774 (Pubitemid 29018775)
9. Van Den Bosch, L., Tilkin, P., Lemmens, G., and Robberecht, W. (2002) Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13, 1067-1070 (Pubitemid 34587742)
10. Peri, F., and Nusslein-Volhard, C. (2008) Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell 133, 916-927 (Pubitemid 351707689)
11. Venneti, S., Wiley, C. A., and Kofler, J. (2009) Imaging microglial activation during neuroinflammation and Alzheimer's disease. J. Neuroimmune Pharmacol. 4, 227-243
12. Lull, M. E., and Block, M. L. Microglial activation and chronic neurodegeneration. Neurotherapeutics 7, 354-365
13. Hickman, S. E., and El Khoury, J. Mechanisms of mononuclear phagocyte recruitment in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 9, 168-173
14. Woodruff, T. M., Ager, R. R., Tenner, A. J., Noakes, P. G., and Taylor, S. M. The role of the complement system and the activation fragment C5a in the central nervous system. Neuromol. Med. 12, 179-192
15. Morgan, B. P., and Gasque, P. (1996) Expression of complement in the brain: role in health and disease. Immunol. Today 17, 461-466 (Pubitemid 26323314)
16. McGeer, P. L., Akiyama, H., Itagaki, S., and McGeer, E. G. (1989) Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107, 341-346
17. Eikelenboom, P., and Stam, F. C. (1982) Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol. 57, 239-242
18. Velazquez, P., Cribbs, D. H., Poulos, T. L., and Tenner, A. J. (1997) Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Nat. Med. 3, 77-79 (Pubitemid 27019145)
19. Bradt, B. M., Kolb, W. P., and Cooper, N. R. (1998) Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J. Exp. Med. 188, 431-438
20. Ager, R. R., Fonseca, M. I., Chu, S. H., Sanderson, S. D., Taylor, S. M., Woodruff, T. M., and Tenner, A. J. Microglial C5aR (CD88) expression correlates with amyloid-β deposition in murine models of Alzheimer's disease. J. Neurochem. 113, 389-401
21. Fonseca, M. I., Ager, R. R., Chu, S. H., Yazan, O., Sanderson, S. D., LaFerla, F. M., Taylor, S. M., Woodruff, T. M., and Tenner, A. J. (2009) Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease. J. Immunol. 183, 1375-1383
22. Jakob, A. (2010) CNS lupus. J. Neuroinflammation 221, 46-52
23. Wang, Y., Li, Y., Dalle Lucca, S. L., Simovic, M., Tsokos, G. C., and Dalle Lucca, J. J. Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury. J. Neuroinflammation 7, 24
24. Kim, G. H., Mocco, J., Hahn, D. K., Kellner, C. P., Komotar, R. J., Ducruet, A. F., Mack, W. J., and Connolly, E. S., Jr. (2008) Protective effect of C5a receptor inhibition after murine reperfused stroke. Neurosurgery 63, 122-125; discussion 125-126
25. Garrett, M. C., Otten, M. L., Starke, R. M., Komotar, R. J., Magotti, P., Lambris, J. D., Rynkowski, M. A., and Connolly, E. S. (2009) Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage. Brain Res. 1298, 171-177
26. Sewell, D. L., Nacewicz, B., Liu, F., Macvilay, S., Erdei, A., Lambris, J. D., Sandor, M., and Fabry, Z. (2004) Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophil extravasation by C5a receptor antagonist. J. Neuroimmunol. 155, 55-63 (Pubitemid 39165777)
27. Lambert, C., Ase, A. R., Seguela, P., and Antel, J. P. Distinct migratory and cytokine responses of human microglia and macrophages to ATP. Brain Behav. Immun. 24, 1241-1248
28. Samuels, S. E., Lipitz, J. B., Dahl, G., and Muller, K. J. Neuroglial ATP release through innexin channels controls microglial cell movement to a nerve injury. J. Gen. Physiol. 136, 425-442
29. 2+ signaling in glial cell pathology in the central nervous system. Eur. J. Pharmacol. 447, 247-260
30. Honda, S., Sasaki, Y., Ohsawa, K., Imai, Y., Nakamura, Y., Inoue, K., and Kohsaka, S. (2001) Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 21, 1975-1982 (Pubitemid 32221381)
31. Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W. B., and Julius, D. (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512-1519 (Pubitemid 44862659)
32. Kurpius, D., Nolley, E. P., and Dailey, M. E. (2007) Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 55, 873-884
33. Inoue, K. (2002) Microglial activation by purines and pyrimidines. Glia 40, 156-163
34. Choi, M. S., Cho, K. S., Shin, S. M., Ko, H. M., Kwon, K. J., Shin, C. Y., and Ko, K. H. ATP induced microglial cell migration through non-transcriptional activation of matrix metalloproteinase-9. Arch Pharm. Res. 33, 257-265
35. Newman, E. A. (2001) Propagation of intercellular calcium waves in retinal astrocytes and Muller cells. J. Neurosci. 21, 2215-2223
36. Gyoneva, S., Orr, A. G., and Traynelis, S. F. (2009) Differential regulation of microglial motility by ATP/ADP and adenosine. Parkinsonism Relat. Disord. 15(Suppl. 3), S195-S199
37. Degrell, I., and Niklasson, F. (1988) Purine metabolites in the CSF in presenile and senile dementia of Alzheimer type, and in multi infarct dementia. Arch. Gerontol. Geriatr. 7, 173-178
38. Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., and Di Virgilio, F. (2009) Activation of microglia by amyloid β requires P2X7 receptor expression. J. Immunol. 182, 4378-4385
39. Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., and Pericak-Vance, M. A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923
40. Seshadri, S., Fitzpatrick, A. L., Ikram, M. A., DeStefano, A. L., Gudnason, V., Boada, M., Bis, J. C., Smith, A. V., Carassquillo, M. M., Lambert, J. C., Harold, D., Schrijvers, E. M., Ramirez-Lorca, R., Debette, S., Longstreth, W. T., Jr., Janssens, A. C., Pankratz, V. S., Dartigues, J. F., Hollingworth, P., Aspelund, T., Hernandez, I., Beiser, A., Kuller, L. H., Koudstaal, P. J., Dickson, D. W., Tzourio, C., Abraham, R., Antunez, C., Du, Y., Rotter, J. I., Aulchenko, Y. S., Harris, T. B., Petersen, R. C., Berr, C., Owen, M. J., Lopez-Arrieta, J., Varadarajan, B. N., Becker, J. T., Rivadeneira, F., Nalls, M. A., Graff-Radford, N. R., Campion, D., Auerbach, S., Rice, K., Hofman, A., Jonsson, P. V., Schmidt, H., Lathrop, M., Mosley, T. H., Au, R., Psaty, B. M., Uitterlinden, A. G., Farrer, L. A., Lumley, T., Ruiz, A., Williams, J., Amouyel, P., Younkin, S. G., Wolf, P. A., Launer, L. J., Lopez, O. L., van Duijn, C. M., and Breteler, M. M. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303, 1832-1840
41. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A. R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M. K., Brayne, C., Rubinsztein, D. C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K. S., Passmore, P. A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A. D., Love, S., Kehoe, P. G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A. M., Kauwe, J. S., Cruchaga, C., Nowotny, P., Morris, J. C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P. P., Van Broeckhoven, C., Livingston, G., Bass, N. J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C. E., Tsolaki, M., Singleton, A. B., Guerreiro, R., Muhleisen, T. W., Nothen, M. M., Moebus, S., Jockel, K. H., Klopp, N., Wichmann, H. E., Carrasquillo, M. M., Pankratz, V. S., Younkin, S. G., Holmans, P. A., O'Donovan, M., Owen, M. J., and Williams, J. (2009) Genomewide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088-1093
42. Beecham, G. W., Martin, E. R., Li, Y. J., Slifer, M. A., Gilbert, J. R., Haines, J. L., and Pericak-Vance, M. A. (2009) Genomewide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am. J. Hum. Genet. 84, 35-43
43. Kim, J., Basak, J. M., and Holtzman, D. M. (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303
44. Lee, C. Y., and Landreth, G. E. The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117, 949-960
45. Colton, C. A., Needham, L. K., Brown, C., Cook, D., Rasheed, K., Burke, J. R., Strittmatter, W. J., Schmechel, D. E., and Vitek, M. P. (2004) APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J. Neuroimmunol. 147, 62-67 (Pubitemid 38114948)
46. Barger, S. W., and Harmon, A. D. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878-881
47. Belinson, H., and Michaelson, D. M. (2009) ApoE4-dependent Aβ-mediated neurodegeneration is associated with inflammatory activation in the hippocampus but not the septum. J. Neural Transm. 116, 1427-1434
48. Maezawa, I., Nivison, M., Montine, K. S., Maeda, N., and Montine, T. J. (2006) Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. FASEB J. 20, 797-799 (Pubitemid 46671219)
49. Maezawa, I., Zaja-Milatovic, S., Milatovic, D., Stephen, C., Sokal, I., Maeda, N., Montine, T. J., and Montine, K. S. (2006) Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity. J. Neuroinflammation 3, 21
50. Pocivavsek, A., Burns, M. P., and Rebeck, G. W. (2009) Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase. Glia 57, 444-453
51. Egensperger, R., Kosel, S., von Eitzen, U., and Graeber, M. B. (1998) Microglial activation in Alzheimer disease: Association with APOE genotype. Brain Pathol. 8, 439-447
52. Simard, A. R., Soulet, D., Gowing, G., Julien, J. P., and Rivest, S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502 (Pubitemid 43221886)
53. Keene, C. D., Chang, R. C., Lopez-Yglesias, A. H., Shalloway, B. R., Sokal, I., Li, X., Reed, P. J., Keene, L. M., Montine, K. S., Breyer, R. M., Rockhill, J. K., and Montine, T. J. Suppressed accumulation of cerebral amyloid peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow. Am. J. Pathol. 177, 346-354
54. Xu, P. T., Schmechel, D., Rothrock-Christian, T., Burkhart, D. S., Qiu, H. L., Popko, B., Sullivan, P., Maeda, N., Saunders, A. M., Roses, A. D., and Gilbert, J. R. (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3, 229-245
55. Sullivan, P. M., Mezdour, H., Aratani, Y., Knouff, C., Najib, J., Reddick, R. L., Quarfordt, S. H., and Maeda, N. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972-17980 (Pubitemid 27306374)
56. Cimino, P. J., Sokal, I., Leverenz, J., Fukui, Y., and Montine, T. J. (2009) DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain. Am. J. Pathol. 175, 1622-1630
57. Miller, A. M., and Stella, N. (2009) Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method. Glia 57, 875-883
58. Christie, R. H., Freeman, M., and Hyman, B. T. (1996) Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease. Am. J. Pathol. 148, 399-403
59. 2-macroglobulin receptor/low density lipoprotein receptor-related protein (LRP) in rat microglial cells. J. Neurosci. Res. 60, 401-411
60. Zhang, C., An, J., Strickland, D. K., and Yepes, M. (2009) The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am. J. Pathol. 174, 586-594
61. Egger, M., Beer, A. G., Theurl, M., Schgoer, W., Hotter, B., Tatarczyk, T., Vasiljevic, D., Frauscher, S., Marksteiner, J., Patsch, J. R., Schratzberger, P., Djanani, A. M., Mahata, S. K., and Kirchmair, R. (2008) Monocyte migration: a novel effect and signaling pathways of catestatin. Eur. J. Pharmacol. 598, 104-111
62. Irino, Y., Nakamura, Y., Inoue, K., Kohsaka, S., and Ohsawa, K. (2008) Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. J. Neurosci. Res. 86, 1511-1519 (Pubitemid 351642444)
63. Calvo, M., Zhu, N., Tsantoulas, C., Ma, Z., Grist, J., Loeb, J. A., and Bennett, D. L. Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J. Neurosci. 30, 5437-5450
64. Inoue, K. (2008) Purinergic systems in microglia. Cell. Mol. Life Sci. 65, 3074-3080
65. Horvath, R. J., and DeLeo, J. A. (2009) Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J. Neurosci. 29, 998-1005
66. Ward, P. A. (2009) Functions of C5a receptors. J. Mol. Med. 87, 375-378
67. Mahley, R. W., and Rall, S. C. (2000) Apolipoprotein E: Far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 01, 507-537